mRNA differential display of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors Sarah J. Roberts-ThomsonElizabeth G. Snyderwine OriginalPaper Pages: 99 - 107
c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value Rafael MolinaJudith JoAntonio M. Ballesta OriginalPaper Pages: 109 - 119
Suspected spinal cord compression in breast cancer patients: A multidisciplinary risk assessment Charles LuPaul C. StomperJames A. Talcott OriginalPaper Pages: 121 - 131
Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up? Romano DemicheliMonica TerenzianiGianni Bonadonna OriginalPaper Pages: 133 - 137
Uptake and distribution of doxorubicin in hormone-manipulated human breast cancer cells in vitro Marijke BontenbalAnieta M. SieuwertsJan G.M. Klijn OriginalPaper Pages: 139 - 148
Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells M. Fathy El EtrebyYayun LiangPatricia V. Schoenlein OriginalPaper Pages: 149 - 168
Expanded phase II trial of paclitaxel in metastatic breast cancer: A Southwest Oncology Group study Charles E. Geyer Jr.Stephanie J. GreenSilvana Martino OriginalPaper Pages: 169 - 181
Adrenal androgens and human breast cancer: A new appraisal John B. Adams OriginalPaper Pages: 183 - 188